Japanese Journal of Biometrics
Online ISSN : 2185-6494
Print ISSN : 0918-4430
ISSN-L : 0918-4430
Theme 3: Points to Consider on Multiplicity Issues in Clinical Trials
Points to Consider on Multiplicity Issues in Clinical Trials
Hiroyuki WatanabeKenichi Takahashi
Author information
JOURNAL FREE ACCESS

2006 Volume 27 Issue Special_Issue Pages S73-S77

Details
Abstract
We would like to provide ideas about multiplicity from the practical point of view of a statistician in a pharmaceutical company. We think that a trial statistician should satisfy not only the requirements, described in ICH-E9, but should also be responsible for explaining statistical analyses, which may be complicated, to non-statisticians in simple language. In addition, certain multiple comparison methods that have been recently developed are hard to understand even for statisticians dealing with clinical trials. When these methods are applied to clinical trials, it is almost impossible to understand the essence of the multiple comparisons and interpret the results correctly. Therefore it is essential to plan a simple confirmatory clinical trial that can be interpreted clearly.
Content from these authors
© 2006 The Biometric Society of Japan
Previous article Next article
feedback
Top